Reovirus activates a caspase-independent cell death pathway

mBio

Volumn 4, Issue 3, 2013, Pages

  Berger, Angela K ^a   Danthi, Pranav ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECEPTOR INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REOVIRUS; RNA SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL LINE; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; METABOLISM; PATHOGENICITY; PHYSIOLOGY; REOVIRIDAE;

MAMMALIA; MIRIDAE; ORTHOREOVIRUS;

ANIMALS; CASPASES; CELL DEATH; CELL LINE; GENE EXPRESSION PROFILING; MICE; REOVIRIDAE; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84879590236     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00178-13     Document Type: Article

References (83)

1. Mocarski ES, Upton JW, Kaiser WJ. 2012. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 12:79-88.
2. Lamkanfi M, Dixit VM. 2010. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8:44-54.
3. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nuñez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G. 2012. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19:107-120.
4. Kono H, Rock KL. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8:279-289.
5. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J. 2008. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135:1311-1323.
6. Richardson-Burns SM, Tyler KL. 2004. Regional differences in viral growth and central nervous system injury correlate with apoptosis. J. Virol. 78:5466-5475.
7. Oberhaus SM, Smith RL, Clayton GH, Dermody TS, Tyler KL. 1997. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J. Virol. 71:2100-2106.
8. DeBiasi RL, Robinson BA, Sherry B, Bouchard R, Brown RD, Rizeq M, Long C, Tyler KL. 2004. Caspase inhibition protects against reovirusinduced myocardial injury in vitro and in vivo. J. Virol. 78:11040-11050.
9. Clarke P, Beckham JD, Leser JS, Hoyt CC, Tyler KL. 2009. Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J. Virol. 83:6161-6170.
10. Berens HM, Tyler KL. 2011. The proapoptotic Bcl-2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis. J. Virol. 85: 3858-3871.
11. Beckham JD, Goody RJ, Clarke P, Bonny C, Tyler KL. 2007. A novel strategy for the treatment of viral CNS infection utilizing a cell-permeable inhibitor of c-Jun N-terminal kinase. J. Virol. 81:6984-6992.
12. O'Donnell SM, Hansberger MW, Connolly JL, Chappell JD, Watson MJ, Pierce JM, Wetzel JD, Han W, Barton ES, Forrest JC, Valyi-Nagy T, Yull FE, Blackwell TS, Rottman JN, Sherry B, Dermody TS. 2005. Organ-specific roles for transcription factor NFB in reovirus-induced apoptosis and disease. J. Clin. Invest. 115:2341-2350.
13. Holm GH, Pruijssers AJ, Li L, Danthi P, Sherry B, Dermody TS. 2010. Interferon regulatory factor-3 attenuates reovirus myocarditis and contributes to viral clearance. J. Virol. 84:6900-6908.
14. Danthi P, Pruijssers AJ, Berger AK, Holm GH, Zinkel SS, Dermody TS. 2010. Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog. 6:e1000980. http://dx.doi.org/10.1371/journal.ppat.1000980.
15. Danthi P, Kobayashi T, Holm GH, Hansberger MW, Abel TW, Dermody TS. 2008. Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J. Virol. 82:161-172.
16. Danthi P, Coffey CM, Parker JS, Abel TW, Dermody TS. 2008. Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain. PLoS Pathog. 4:e1000248. http://dx.doi.org/10.1371/journal.ppat.1000248.
17. Danthi P, Holm GH, Stehle T, Dermody TS. 2013. Reovirus receptors, cell entry, and signaling, p 1-30. In Pöhlmann S, Simmons G (ed), Viral entry into cells. Landes Bioscience, Georgetown, TX.
18. Danthi P, Guglielmi KM, Kirchner E, Mainou B, Stehle T, Dermody TS. 2010. From touchdown to transcription: the reovirus cell entry pathway. Curr. Top. Microbiol. Immunol. 343:91-119.
19. Connolly JL, Dermody TS. 2002. Virion disassembly is required for apoptosis induced by reovirus. J. Virol. 76:1632-1641.
20. Connolly JL, Rodgers SE, Clarke P, Ballard DW, Kerr LD, Tyler KL, Dermody TS. 2000. Reovirus-induced apoptosis requires activation of transcription factor NF-B. J. Virol. 74:2981-2989.
21. Hansberger MW, Campbell JA, Danthi P, Arrate P, Pennington KN, Marcu KB, Ballard DW, Dermody TS. 2007. I B kinase subunits α and γ are required for activation of NF-B and induction of apoptosis by mammalian reovirus. J. Virol. 81:1360-1371.
22. Kominsky DJ, Bickel RJ, Tyler KL. 2002. Reovirus-induced apoptosis requires both death receptorand mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ. 9:926-933.
23. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
24. Li H, Zhu H, Xu CJ, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
25. Kominsky DJ, Bickel RJ, Tyler KL. 2002. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J. Virol. 76:11414-11424.
26. Holm GH, Zurney J, Tumilasci V, Leveille S, Danthi P, Hiscott J, Sherry B, Dermody TS. 2007. Retinoic acid-inducible gene-I and interferon-beta promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J. Biol. Chem. 282:21953-21961.
27. Debiasi RL, Squier MK, Pike B, Wynes M, Dermody TS, Cohen JJ, Tyler KL. 1999. Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J. Virol. 73: 695-701.
28. Clarke P, Meintzer SM, Wang Y, Moffitt LA, Richardson-Burns SM, Johnson GL, Tyler KL. 2004. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J. Virol. 78:13132-13138.
29. Clarke P, Meintzer SM, Widmann C, Johnson GL, Tyler KL. 2001. Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J. Virol. 75:11275-11283.
30. Tyler KL, Squier MK, Rodgers SE, Schneider BE, Oberhaus SM, Grdina TA, Cohen JJ, Dermody TS. 1995. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J. Virol. 69:69726979.
31. Tyler KL, Squier MK, Brown AL, Pike B, Willis D, Oberhaus SM, Dermody TS, Cohen JJ. 1996. Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes. J. Virol. 70:7984-7991.
32. Rodgers SE, Barton ES, Oberhaus SM, Pike B, Gibson CA, Tyler KL, Dermody TS. 1997. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J. Virol. 71:2540-2546.
33. Connolly JL, Barton ES, Dermody TS. 2001. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J. Virol. 75: 4029-4039.
34. Clarke P, Debiasi RL, Meintzer SM, Robinson BA, Tyler KL. 2005. Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis 10:513-524.
35. Ribble D, Goldstein NB, Norris DA, Shellman YG. 2005. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 5:12.
36. Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
37. Ziegelbauer K, Gantner F, Lukacs NW, Berlin A, Fuchikami K, Niki T, Sakai K, Inbe H, Takeshita K, Ishimori M, Komura H, Murata T, Lowinger T, Bacon KB. 2005. A selective novel low-molecular-weight inhibitor of I B kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity. Br. J. Pharmacol. 145: 178-192.
38. Clarke P, Meintzer SM, Moffitt LA, Tyler KL. 2003. Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virusinfected cells. J. Biol. Chem. 278:18092-18100.
39. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. 2007. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ. 14:400-410.
40. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11:700-714.
41. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J. 2008. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4:313-321.
42. Degterev A, Maki JL, Yuan J. 2013. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 20:366.
43. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A, Yuan J, Vandenabeele P. 2012. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3:e437. http://dx.doi.org/10.1038/cddis.2012.176.
44. Golstein P, Kroemer G. 2007. Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32:37-43.
45. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. 1997. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1481-1486.
46. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
47. Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, Cain K, MacFarlane M, Häcker G, Leverkus M. 2011. cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43: 449-463.
48. Krysko DV, Vanden Berghe T, D'Herde K, Vandenabeele P. 2008. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44:205-221.
49. Danthi P, Hansberger MW, Campbell JA, Forrest JC, Dermody TS. 2006. JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis. J. Virol. 80:1261-1270.
50. He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X. 2009. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137:1100-1111.
51. Clarke P, Meintzer SM, Gibson S, Widmann C, Garrington TP, Johnson GL, Tyler KL. 2000. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74:8135-8139.
52. Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K, Meier P. 2011. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43:432-448.
53. Upton JW, Kaiser WJ, Mocarski ES. 2012. Dai/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11:290-297.
54. Bertrand MJ, Vandenabeele P. 2011. The Ripoptosome: death decision in the cytosol. Mol. Cell 43:323-325.
55. Marcato P, Shmulevitz M, Pan D, Stoltz D, Lee PW. 2007. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol. Ther. 15: 1522-1530.
56. Wisniewski ML, Werner BG, Hom LG, Anguish LJ, Coffey CM, Parker JS. 2011. Reovirus infection or ectopic expression of outer capsid protein micro1 induces apoptosis independently of the cellular proapoptotic proteins Bax and Bak. J. Virol. 85:296-304.
57. Coffey CM, Sheh A, Kim IS, Chandran K, Nibert ML, Parker JS. 2006. Reovirus outer capsid protein micro1 induces apoptosis and associates with lipid droplets, endoplasmic reticulum, and mitochondria. J. Virol. 80:8422-8438.
58. Knowlton JJ, Dermody TS, Holm GH. 2012. Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3and NF-B-dependent expression of noxa. J. Virol. 86:1650-1660.
59. Beckham JD, Tuttle KD, Tyler KL. 2010. Caspase-3 activation is required for reovirus-induced encephalitis in vivo. J. Neurovirol. 16:306-317.
60. Barton ES, Youree BE, Ebert DH, Forrest JC, Connolly JL, Valyi-Nagy T, Washington K, Wetzel JD, Dermody TS. 2003. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J. Clin. Invest. 111:1823-1833.
61. Papadimitriou JM. 1968. The biliary tract in acute murine reovirus 3 infection. Light and electron microscopic study. Am. J. Pathol. 52: 595-601.
62. Derrien M, Hooper JW, Fields BN. 2003. The M2 gene segment is involved in the capacity of reovirus type 3Abney to induce the oily fur syndrome in neonatal mice, a S1 gene segment-associated phenotype. Virology 305:25-30.
63. Wilson GA, Morrison LA, Fields BN. 1994. Association of the reovirus S1 gene with serotype 3-induced biliary atresia in mice. J. Virol. 68: 6458-6465.
64. Sherry B, Schoen FJ, Wenske E, Fields BN. 1989. Derivation and characterization of an efficiently myocarditic reovirus variant. J. Virol. 63: 4840-4849.
65. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young JA. 1996. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avianleukosis-sarcoma viruses and mediates apoptosis. Cell 87:845-855.
66. Hanon E, Keil G, van Drunen Littel-van den Hurk S, Griebel P, Vanderplasschen A, Rijsewijk FA, Babiuk L, Pastoret PP. 1999. Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D. Virology 257:191-197.
67. Gosselin AS, Simonin Y, Guivel-Benhassine F, Rincheval V, Vayssière JL, Mignotte B, Colbère-Garapin F, Couderc T, Blondel B. 2003. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J. Virol. 77:790-798.
68. Liu Y, Pu Y, Zhang X. 2006. Role of the mitochondrial signaling pathway in murine coronavirus-induced oligodendrocyte apoptosis. J. Virol. 80: 395-403.
69. Jan JT, Griffin DE. 1999. Induction of apoptosis by sindbis virus occurs at cell entry and does not require viral replication. J. Virol. 73:10296-10302.
70. Chinchar VG, Bryan L, Wang J, Long S, Chinchar GD. 2003. Induction of apoptosis in frog virus 3-infected cells. Virology 306:303-312.
71. Ramsey-Ewing A, Moss B. 1998. Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells. Virology 242: 138-149.
72. Labrada L, Bodelón G, Viñuela J, Benavente J. 2002. Avian reoviruses cause apoptosis in cultured cells: viral uncoating, but not viral gene expression, is required for apoptosis induction. J. Virol. 76:7932-7941.
73. Mortola E, Noad R, Roy P. 2004. Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J. Virol. 78: 2875-2883.
74. Chan FK, Shisler J, Bixby JG, Felices M, Zheng L, Appel M, Orenstein J, Moss B, Lenardo MJ. 2003. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278:51613-51621.
75. Chu JJ, Ng ML. 2003. The mechanism of cell death during west Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 84: 3305-3314.
76. Li M, Beg AA. 2000. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J. Virol. 74:7470-7477.
77. Kobayashi T, Ooms LS, Ikizler M, Chappell JD, Dermody TS. 2010. An improved reverse genetics system for mammalian orthoreoviruses. Virology 398:194-200.
78. Kobayashi T, Antar AA, Boehme KW, Danthi P, Eby EA, Guglielmi KM, Holm GH, Johnson EM, Maginnis MS, Naik S, Skelton WB, Wetzel JD, Wilson GJ, Chappell JD, Dermody TS. 2007. A plasmidbased reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 1:147-157.
79. Berard A, Coombs KM. 2009. Mammalian reoviruses: propagation, quantification, and storage. Curr. Protoc. Microbiol. Chapter 15: Unit15C.11.
80. Virgin HW, IV, Bassel-Duby R, Fields BN, Tyler KL. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604.
81. Smith RE, Zweerink HJ, Joklik WK. 1969. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39: 791-810.
82. Wetzel JD, Chappell JD, Fogo AB, Dermody TS. 1997. Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses. J. Virol. 71:299-306.
83. Becker MM, Peters TR, Dermody TS. 2003. Reovirus sigma NS and mu NS proteins form cytoplasmic inclusion structures in the absence of viral infection. J. Virol. 77:5948-5963.